350 related articles for article (PubMed ID: 33333224)
1. New insights into TNFα/PTP1B and PPARγ pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease.
Sarkar P; Thirumurugan K
Gene; 2021 Mar; 771():145340. PubMed ID: 33333224
[TBL] [Abstract][Full Text] [Related]
2. In silico explanation for the causalities of deleterious RNF213 SNPs in Moyamoya disease and insulin resistance.
Sarkar P; Thirumurugan K
Comput Biol Chem; 2021 Jun; 92():107488. PubMed ID: 33930741
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNFα action in obesity.
Song DD; Chen Y; Li ZY; Guan YF; Zou DJ; Miao CY
Biochim Biophys Acta; 2013 Aug; 1831(8):1368-76. PubMed ID: 23711960
[TBL] [Abstract][Full Text] [Related]
4. Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity.
Li P; Song Y; Zan W; Qin L; Han S; Jiang B; Dou H; Shao C; Gong Y
Diabetes; 2017 Feb; 66(2):300-313. PubMed ID: 27899484
[TBL] [Abstract][Full Text] [Related]
5. Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
Kong P; Chi R; Zhang L; Wang N; Lu Y
Fitoterapia; 2013 Dec; 91():44-50. PubMed ID: 23978582
[TBL] [Abstract][Full Text] [Related]
6. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.
Zabolotny JM; Kim YB; Welsh LA; Kershaw EE; Neel BG; Kahn BB
J Biol Chem; 2008 May; 283(21):14230-41. PubMed ID: 18281274
[TBL] [Abstract][Full Text] [Related]
7. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease.
Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T
Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes.
Vazquez-Prieto MA; Bettaieb A; Haj FG; Fraga CG; Oteiza PI
Arch Biochem Biophys; 2012 Nov; 527(2):113-8. PubMed ID: 22425757
[TBL] [Abstract][Full Text] [Related]
9. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes.
Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS
PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
12. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
13. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli.
Miranda S; González-Rodríguez A; Revuelta-Cervantes J; Rondinone CM; Valverde AM
Cell Signal; 2010 Apr; 22(4):645-59. PubMed ID: 20026400
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
16. Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
Key J; Maletzko A; Kohli A; Gispert S; Torres-Odio S; Wittig I; Heidler J; Bárcena C; López-Otín C; Lei Y; West AP; Münch C; Auburger G
Neurogenetics; 2020 Jul; 21(3):187-203. PubMed ID: 32342250
[TBL] [Abstract][Full Text] [Related]
17. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
18. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent manner.
Takeda M; Tezuka T; Kim M; Choi J; Oichi Y; Kobayashi H; Harada KH; Mizushima T; Taketani S; Koizumi A; Youssefian S
Biochem Biophys Res Commun; 2020 May; 525(3):668-674. PubMed ID: 32139119
[TBL] [Abstract][Full Text] [Related]
19. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
20. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity.
Yao F; Yu Y; Feng L; Li J; Zhang M; Lan X; Yan X; Liu Y; Guan F; Zhang M; Chen L
Exp Cell Res; 2017 Jun; 355(2):105-112. PubMed ID: 28365247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
